Larimar started at buy by Truist on Friedreich's ataxia drug
Truist has initiated coverage of Larimar (LRMR) with a buy rating, citing an "asymmetric" risk/reward ahead of regulatory ...
Scholar Rock submits FDA application for SMA treatment
CAMBRIDGE, Mass. - Scholar Rock (NASDAQ: SRRK), a biopharmaceutical company with a market capitalization of $3.96 billion and an impressive 362.73% stock price surge over the past six months, ...
Truist Financial Increases Cloudflare (NYSE:NET) Price Target to $140.00
Cloudflare (NYSE:NET – Free Report) had its price objective lifted by Truist Financial from $120.00 to $140.00 in a research report released on Tuesday,Benzinga reports. The brokerage currently has a ...
Truist maintains Roper stock Buy rating, $665 target
In addition to revenue, the firm has increased its estimates for Roper's EBITDA and free cash flow (FCF) for 2025. The ...
Truist Financial Initiates a Buy Rating on Minerals Technologies (MTX)
Minerals Technologies (MTX – Research Report) received a Buy rating and a $103.00 price target from Truist Financial analyst Pete Osterland ...
Truist Financial Gives a Hold Rating to Snap (SNAP)
In a report released today, Youssef Squali from Truist Financial assigned a Hold rating to Snap (SNAP – Research Report), with a price target ...